Should FDG PET/CT be used for the initial staging of breast cancer?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 10, 2009, Pages 1539-1542

  Groheux, David ^a   Hindié, Elif ^a   Rubello, Domenico ^b   Espié, Marc ^a   Baillet, Georges ^c   Giacchetti, Sylvie ^a   Misset, Jean Louis ^a   Moretti, Jean Luc ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b 'Santa Maria della Misericordia' Hospital   (Italy)

^c PZQ Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AXILLARY LYMPH NODE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISTANT METASTASIS; HUMAN; IMAGE ENHANCEMENT; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NOTE; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODE EXCISION; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350554068     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1159-0     Document Type: Note

References (20)

1. RL Wahl BA Siegel RE Coleman CG Gatsonis PET Study Group 2004 Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group J Clin Oncol 22 277 285 10.1200/JCO.2004.04.148 14722036 10.1200/JCO.2004.04.148 (Pubitemid 41095092)
2. U Veronesi C De Cicco VE Galimberti JR Fernandez N Rotmensz G Viale, et al. 2007 A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases Ann Oncol 18 473 478 10.1093/annonc/mdl425 17164229 10.1093/annonc/mdl425 1:STN:280:DC%2BD2szlt1ajtg%3D%3D (Pubitemid 46359625)
3. Heusner TA, Kuemmel S, Hahn S, Koeninger A, Otterbach F, Hamami ME, et al. Diagnostic value of full-dose FDG-PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging. 2009; In press.
4. SE Singletary C Allred P Ashley LW Bassett D Berry KI Bland, et al. 2002 Revision of the American Joint Committee on Cancer staging system for breast cancer J Clin Oncol 20 3628 3636 10.1200/JCO.2002.02.026 12202663 10.1200/JCO.2002.02.026 (Pubitemid 34983222)
5. Hindié E, Groheux D, Espié M, Bourstyn E, Toubert ME, Sarandi F, et al. Sentinel node biopsy in breast cancer [review]. Bull Cancer 2009; In press.
6. JJ van der Hoeven NC Krak OS Hoekstra EF Comans RP Boom D van Geldere, et al. 2004 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography in staging of locally advanced breast cancer J Clin Oncol 22 1253 1259 10.1200/JCO.2004.07.058 15051773 10.1200/JCO.2004.07.058 (Pubitemid 41079839)
7. S Carkaci HA Macapinlac M Cristofanilli O Mawlawi E Rohren AM Gonzalez Angulo, et al. 2009 Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data J Nucl Med 50 231 238 10.2967/jnumed.108.056010 19164229 10.2967/jnumed.108.056010
8. D Groheux JL Moretti G Baillet M Espie S Giacchetti E Hindie, et al. 2008 Effect of (18) F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer Int J Radiat Oncol Biol Phys 71 695 704 10.1016/j.ijrobp. 2008.02.056 18436392
9. D Fuster J Duch P Paredes M Velasco M Muñoz G Santamaría, et al. 2008 Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures J Clin Oncol 26 4746 4751 10.1200/JCO.2008.17.1496 18695254 10.1200/JCO.2008.17.1496
10. A Gil-Rendo F Martínez-Regueira G Zornoza MJ García-Velloso C Beorlegui N Rodriguez-Spiteri 2009 Association between [18F] fluorodeoxyglucose uptake and prognostic parameters in breast cancer Br J Surg 96 166 170 10.1002/bjs.6459 19160365 10.1002/bjs.6459 1:CAS:528: DC%2BD1MXjsVeqtbY%3D
11. A Berriolo-Riedinger C Touzery JM Riedinger M Toubeau B Coudert L Arnould, et al. 2007 [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy Eur J Nucl Med Mol Imaging 34 1915 1924 10.1007/s00259-007-0459-5 17579854 10.1007/s00259-007-0459-5 1:CAS:528:DC%2BD2sXhtlyiurzL (Pubitemid 350212117)
12. J Schwarz-Dose M Untch R Tiling S Sassen S Mahner S Kahlert, et al. 2009 Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose J Clin Oncol 27 535 541 10.1200/JCO.2008.17.2650 19075273 10.1200/JCO.2008.17.2650
13. DN Danforth Jr L Aloj JA Carrasquillo SL Bacharach C Chow J Zujewski, et al. 2002 The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer Breast Cancer Res Treat 75 135 146 10.1023/A:1019664126220 12243506 10.1023/A:1019664126220 1:CAS:528:DC%2BD38XlvFSquro%3D (Pubitemid 34994949)
14. TF Cermik A Mavi S Basu A Alavi 2008 Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer Eur J Nucl Med Mol Imaging 35 475 483 10.1007/s00259-007-0580-5 17957366 10.1007/s00259-007-0580-5 (Pubitemid 351661670)
15. JR Bellon RB Livingston WB Eubank JR Gralow GK Ellis LK Dunnwald, et al. 2004 Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) Am J Clin Oncol 27 407 410 10.1097/01.coc. 0000128869.19357.9b 15289736 10.1097/01.coc.0000128869.19357.9b (Pubitemid 39045254)
16. B Kuru M Camlibel S Dinc MA Gulcelik H Alagol 2003 Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy Eur J Surg Oncol 29 839 844 10.1016/j.ejso.2003.08.003 14624774 10.1016/j.ejso.2003.08.003 1:STN:280:DC%2BD3srksF2ntw%3D%3D (Pubitemid 37493280)
17. RA Brito V Valero AU Buzdar DJ Booser F Ames E Strom, et al. 2001 Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience J Clin Oncol 19 628 633 11157012 1:CAS:528:DC%2BD3MXhtlGrtrg%3D
18. ER Port H Yeung M Gonen L Liberman J Caravelli P Borgen, et al. 2006 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma Ann Surg Oncol 13 677 684 10.1245/ASO.2006.03.035 16538409 10.1245/ASO.2006.03.035
19. S Mahner S Schirrmacher W Brenner L Jenicke CR Habermann N Avril, et al. 2008 Comparison between positron emission tomography using 2-[fluorine-18] fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer Ann Oncol 19 1249 1254 10.1093/annonc/mdn057 18356138 10.1093/annonc/mdn057 1:STN:280:DC%2BD1cvgvVyisQ%3D%3D (Pubitemid 351911953)
20. T Nakai C Okuyama T Kubota K Yamada Y Ushijima K Taniike, et al. 2005 Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer Eur J Nucl Med Mol Imaging 32 1253 1258 10.1007/s00259-005-1842-8 16133397 10.1007/s00259-005-1842-8 (Pubitemid 41598715)